Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09SFV
|
|||
| Former ID |
DCL000600
|
|||
| Drug Name |
LY294002
|
|||
| Synonyms |
2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; 154447-36-6; LY 294002; LY-294002; 2-morpholino-8-phenyl-4H-chromen-4-one; 2-morpholin-4-yl-8-phenyl-4H-chromen-4-one; UNII-31M2U1DVID; LY-294,002; 2-(morpholin-4-yl)-8-phenyl-4H-chromen-4-one; 31M2U1DVID; 2-MORPHOLIN-4-YL-7-PHENYL-4H-CHROMEN-4-ONE; CHEMBL98350; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-; CHEBI:65329; 2-morpholino-8-phenyl-chromen-4-one; AK162301; 2-(morpholin-4-yl)-8-phenylchromen-4-one; LY2; 15447-36-6; IN1266; IN1268; Lys 294002; BMK1-D5; H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-(9CI); 2-(4-Morpholino)-8-phenyl-4H-1-benzopyran-4-one; 2-morpholin-4-yl-8-phenylchromen-4-one; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl; 4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-(9CI); 8-Phenyl-2-(morpholin-4-yl)-chromen-4-one; 2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Neuroblastoma [ICD-11: 2D11.2; ICD-9: 194] | Phase 1 | [1] | |
| Company |
Genentech
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H17NO3
|
|||
| Canonical SMILES |
C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4
|
|||
| InChI |
1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2
|
|||
| InChIKey |
CZQHHVNHHHRRDU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 154447-36-6
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
525433, 585861, 841119, 3726536, 7429938, 7888714, 7980311, 8152497, 10318978, 10852013, 11111398, 11113937, 11120213, 11120701, 11121189, 11121787, 11122267, 11147296, 11362977, 11365539, 11368101, 11371105, 11371106, 11373702, 11376263, 11439064, 12014870, 14800773, 17396192, 26705044, 26752090, 26752091, 26759070, 26759072, 29223086, 46393655, 46504762, 46509407, 47364938, 47364939, 47810522, 47885186, 47885187, 48110222, 48258971, 49889769, 50104744, 50123961, 53789644, 53800706
|
|||
| ChEBI ID |
CHEBI:65329
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02337309) SF1126 for Patients With Relapsed or Refractory Neuroblastoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Genentech (2009). | |||
| REF 3 | How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.